Global Cardiovascular Devices Market Overview 2023-2028 

The global cardiovascular devices market size reached US$ 55.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028. 

Cardiovascular devices are medical instruments and implants designed to diagnose, monitor, and treat heart diseases and related health issues. They encompass a broad range of products, from stents and pacemakers to defibrillators and heart valves. They are manufactured through multiple phases, including design, prototyping, clinical trials, and mass production, ensuring they meet the highest safety and efficacy standards. They are specifically tailored to support the cardiovascular system, which includes the heart and blood vessels. They facilitate timely interventions by aiding in the accurate diagnosis of conditions. They reduce the risk of cardiovascular events, improve the quality of life of the patient, and enhance heart health. They provide multiple advantages like better patient outcomes, lower hospitalization rates, and more effective healthcare administration overall. They find extensive use in various medical settings, from hospitals to outpatient clinics.

Request a Sample Report:- https://www.imarcgroup.com/cardiovascular-devices-market/requestsample

Global Cardiovascular Devices Market Trends and Drivers:

At present, the rising geriatric population that is more prone to cardiovascular diseases like coronary artery disease, arrhythmias, and heart failure represents one of the key factors impelling the market growth. Additionally, the growing integration of digital technology with cardiovascular devices for enhancing the precision and efficiency of treatments is offering a favorable market outlook. These devices are equipped with connectivity features to monitor patients remotely, reducing hospital visits and enabling proactive healthcare management.

Besides this, the increasing need for cost-effective medical treatments due to economic pressures and healthcare reforms is encouraging cardiovascular device manufacturers to adopt strategies that reduce costs without compromising quality. Moreover, the rising number of regulatory approvals is fast-tracking the availability of advanced cardiovascular devices, ensuring that breakthrough technologies can reach patients in a timely manner. Apart from this, the growing strategic collaborations among key market players, aiming to expand their product portfolios and combine clinical expertise with new-age technologies to innovate and refine cardiovascular devices, are enhancing their efficacy and safety profiles.

Furthermore, the increasing patient engagement and awareness about cardiovascular health is catalyzing the demand for devices that facilitate self-management, such as home blood pressure monitors and wearable cardiac monitors. In addition, the rising emphasis on improving the quality of life of patients with cardiovascular diseases is driving the adoption of devices that offer greater comfort, mobility, and ease of use, providing medical efficacy and a better overall experience. Besides this, the growing integration of genomics in cardiovascular devices, enabling personalized treatments based on the genetic makeup of the patient, is positively influencing the market. Moreover, the increasing incorporation of advanced imaging technologies with cardiovascular devices for enhancing the precision of diagnostics and interventions is bolstering the market growth. This high-definition imaging and 3D mapping are improving the accuracy of procedures, such as catheterizations and the placement of stents, thereby improving outcomes and reducing risk.

Global Cardiovascular Devices Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Abbott Laboratories, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, LivaNova PLC, Medtronic PLC, Siemens Healthineers GmbH (Siemens AG) and Terumo Cardiovascular Systems Corporation (Terumo Corporation)

The report segmented the market on the basis of region, device type, application and end user.

Breakup by Device Type:

  • Diagnostic and Monitoring Devices
  • Electrocardiogram (ECG)
  • Remote Cardiac Monitoring
  • Others
  • Therapeutic and Surgical Devices
  • Cardiac Rhythm Management (CRM) Devices
  • Catheter
  • Stents
  • Heart Valves
  • Others

Breakup by Application:

  • Coronary Artery Disease (CAD)
  • Cardiac Arrhythmia
  • Heart Failure
  • Others

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800